Chemistry analyzer A

Glucose · method comparison · Chemistry analyzer A

Glucose (mg/dL) · Method comparison

Criteria met

4 of 4 questions judged · 4 questions met

Instrument
Chemistry analyzer A (CA-41027)
Comparator
Chemistry analyzer B
Test method
Chemistry analyzer A
Study date
Sep 10, 2026

Table 1. Acceptance criteria

QuestionLimitFindingResult
Individual specimen agreementAt least 95% of specimens within ±6 mg/dL or ±8% of the comparative result, whichever is greater39 of 40 within
Bias at 70 mg/dL|Bias| ≤ 3 mg/dL at 70 mg/dL+1.6 mg/dL1.6 mg/dL from target
Bias at 126 mg/dL|Bias| ≤ 4% at 126 mg/dL+2.4 mg/dL1.9% from target
Bias at 200 mg/dL|Bias| ≤ 4% at 200 mg/dL+3.4 mg/dL1.7% from target
02004006000200400600Chemistry analyzer A (mg/dL)Chemistry analyzer B (mg/dL)Specimen MC-01: comparative 102, test 104 mg/dL, group 1Specimen MC-02: comparative 131, test 132 mg/dL, group 1Specimen MC-03: comparative 641, test 642 mg/dL, group 1Specimen MC-04: comparative 93, test 96 mg/dL, group 1Specimen MC-05: comparative 149, test 153 mg/dL, group 1Specimen MC-06: comparative 468, test 467 mg/dL, group 1Specimen MC-07: comparative 106, test 107 mg/dL, group 1Specimen MC-08: comparative 163, test 136 mg/dL, group 1Specimen MC-09: comparative 421, test 432 mg/dL, group 1Specimen MC-10: comparative 157, test 159 mg/dL, group 1Specimen MC-11: comparative 71, test 73 mg/dL, group 1Specimen MC-12: comparative 142, test 145 mg/dL, group 1Specimen MC-13: comparative 171, test 171 mg/dL, group 1Specimen MC-14: comparative 117, test 117 mg/dL, group 1Specimen MC-15: comparative 182, test 186 mg/dL, group 1Specimen MC-16: comparative 205, test 206 mg/dL, group 1Specimen MC-17: comparative 194, test 200 mg/dL, group 1Specimen MC-18: comparative 74, test 74 mg/dL, group 1Specimen MC-19: comparative 218, test 222 mg/dL, group 1Specimen MC-20: comparative 517, test 526 mg/dL, group 1Specimen MC-21: comparative 347, test 354 mg/dL, group 1Specimen MC-22: comparative 122, test 124 mg/dL, group 1Specimen MC-23: comparative 97, test 98 mg/dL, group 1Specimen MC-24: comparative 55, test 55 mg/dL, group 1Specimen MC-25: comparative 318, test 319 mg/dL, group 1Specimen MC-26: comparative 84, test 86 mg/dL, group 1Specimen MC-27: comparative 249, test 255 mg/dL, group 1Specimen MC-28: comparative 79, test 81 mg/dL, group 1Specimen MC-29: comparative 163, test 166 mg/dL, group 1Specimen MC-30: comparative 126, test 129 mg/dL, group 1Specimen MC-31: comparative 291, test 299 mg/dL, group 1Specimen MC-32: comparative 111, test 114 mg/dL, group 1Specimen MC-33: comparative 42, test 44 mg/dL, group 1Specimen MC-34: comparative 68, test 69 mg/dL, group 1Specimen MC-35: comparative 88, test 89 mg/dL, group 1Specimen MC-36: comparative 574, test 587 mg/dL, group 1Specimen MC-37: comparative 233, test 233 mg/dL, group 1Specimen MC-38: comparative 382, test 384 mg/dL, group 1Specimen MC-39: comparative 268, test 271 mg/dL, group 1Specimen MC-40: comparative 63, test 65 mg/dL, group 1Decision level 70 mg/dL: bias +1.6 mg/dLDecision level 126 mg/dL: bias +2.4 mg/dLDecision level 200 mg/dL: bias +3.4 mg/dL70126200Passing–Babloky = xDecision level
Figure 1. Test against comparative method.
−60−40−2002040600200400600Test − comparative (mg/dL)Comparative result (mg/dL)Specimen MC-01: difference +2.0 mg/dL, allowed ±8.2 mg/dL, group 1, within limitSpecimen MC-02: difference +1.0 mg/dL, allowed ±10.5 mg/dL, group 1, within limitSpecimen MC-03: difference +1.0 mg/dL, allowed ±51.3 mg/dL, group 1, within limitSpecimen MC-04: difference +3.0 mg/dL, allowed ±7.4 mg/dL, group 1, within limitSpecimen MC-05: difference +4.0 mg/dL, allowed ±11.9 mg/dL, group 1, within limitSpecimen MC-06: difference −1.0 mg/dL, allowed ±37.4 mg/dL, group 1, within limitSpecimen MC-07: difference +1.0 mg/dL, allowed ±8.5 mg/dL, group 1, within limitSpecimen MC-08: difference −27.0 mg/dL, allowed ±13.0 mg/dL, group 1, outside limitSpecimen MC-09: difference +11.0 mg/dL, allowed ±33.7 mg/dL, group 1, within limitSpecimen MC-10: difference +2.0 mg/dL, allowed ±12.6 mg/dL, group 1, within limitSpecimen MC-11: difference +2.0 mg/dL, allowed ±6.0 mg/dL, group 1, within limitSpecimen MC-12: difference +3.0 mg/dL, allowed ±11.4 mg/dL, group 1, within limitSpecimen MC-13: difference 0.0 mg/dL, allowed ±13.7 mg/dL, group 1, within limitSpecimen MC-14: difference 0.0 mg/dL, allowed ±9.4 mg/dL, group 1, within limitSpecimen MC-15: difference +4.0 mg/dL, allowed ±14.6 mg/dL, group 1, within limitSpecimen MC-16: difference +1.0 mg/dL, allowed ±16.4 mg/dL, group 1, within limitSpecimen MC-17: difference +6.0 mg/dL, allowed ±15.5 mg/dL, group 1, within limitSpecimen MC-18: difference 0.0 mg/dL, allowed ±6.0 mg/dL, group 1, within limitSpecimen MC-19: difference +4.0 mg/dL, allowed ±17.4 mg/dL, group 1, within limitSpecimen MC-20: difference +9.0 mg/dL, allowed ±41.4 mg/dL, group 1, within limitSpecimen MC-21: difference +7.0 mg/dL, allowed ±27.8 mg/dL, group 1, within limitSpecimen MC-22: difference +2.0 mg/dL, allowed ±9.8 mg/dL, group 1, within limitSpecimen MC-23: difference +1.0 mg/dL, allowed ±7.8 mg/dL, group 1, within limitSpecimen MC-24: difference 0.0 mg/dL, allowed ±6.0 mg/dL, group 1, within limitSpecimen MC-25: difference +1.0 mg/dL, allowed ±25.4 mg/dL, group 1, within limitSpecimen MC-26: difference +2.0 mg/dL, allowed ±6.7 mg/dL, group 1, within limitSpecimen MC-27: difference +6.0 mg/dL, allowed ±19.9 mg/dL, group 1, within limitSpecimen MC-28: difference +2.0 mg/dL, allowed ±6.3 mg/dL, group 1, within limitSpecimen MC-29: difference +3.0 mg/dL, allowed ±13.0 mg/dL, group 1, within limitSpecimen MC-30: difference +3.0 mg/dL, allowed ±10.1 mg/dL, group 1, within limitSpecimen MC-31: difference +8.0 mg/dL, allowed ±23.3 mg/dL, group 1, within limitSpecimen MC-32: difference +3.0 mg/dL, allowed ±8.9 mg/dL, group 1, within limitSpecimen MC-33: difference +2.0 mg/dL, allowed ±6.0 mg/dL, group 1, within limitSpecimen MC-34: difference +1.0 mg/dL, allowed ±6.0 mg/dL, group 1, within limitSpecimen MC-35: difference +1.0 mg/dL, allowed ±7.0 mg/dL, group 1, within limitSpecimen MC-36: difference +13.0 mg/dL, allowed ±45.9 mg/dL, group 1, within limitSpecimen MC-37: difference 0.0 mg/dL, allowed ±18.6 mg/dL, group 1, within limitSpecimen MC-38: difference +2.0 mg/dL, allowed ±30.6 mg/dL, group 1, within limitSpecimen MC-39: difference +3.0 mg/dL, allowed ±21.4 mg/dL, group 1, within limitSpecimen MC-40: difference +2.0 mg/dL, allowed ±6.0 mg/dL, group 1, within limit±6 or 8%Mean±6 or 8%
Figure 2. Differences; dash-dot: allowed difference; dashed: mean difference; ×: outside it.

Table 2. Regression and bias

EstimateValue95% CI
Slope1.0141.000–1.022
Intercept (mg/dL)+0.666−0.6 to 2.0
Mean bias (mg/dL)+2.20.4–4.0

Study details

Matrix
Serum
Method
Hexokinase
Reagent lot
GLU-R2609
Calibrator lot
GLU-C2609
Data
40 included
Replicates
Single
Regression
Passing–Bablok
Comparative range
42–641 mg/dL
Decision levels
70, 126, 200 mg/dL
Alex Rivera, MLS(ASCP)
alex.rivera@example.test
Signed off by
Oct 23, 2026, 13:25 UTCDate

A Data listing

Source: CHEM-B_CHEM-A_glucose_20260910.csv. 40 rows, all included.

Study rowSpecimenComparative (mg/dL)Test (mg/dL)Source row
1MC-011021042
2MC-021311323
3MC-036416424
4MC-0493965
5MC-051491536
6MC-064684677
7MC-071061078
8MC-081631369
9MC-0942143210
10MC-1015715911
11MC-11717312
12MC-1214214513
13MC-1317117114
14MC-1411711715
15MC-1518218616
16MC-1620520617
17MC-1719420018
18MC-18747419
19MC-1921822220
20MC-2051752621
21MC-2134735422
22MC-2212212423
23MC-23979824
24MC-24555525
25MC-2531831926
26MC-26848627
27MC-2724925528
28MC-28798129
29MC-2916316630
30MC-3012612931
31MC-3129129932
32MC-3211111433
33MC-33424434
34MC-34686935
35MC-35888936
36MC-3657458737
37MC-3723323338
38MC-3838238439
39MC-3926827140
40MC-40636541

1 Results

1.1 Specimen decisions

Table 3. Specimen decisions
SpecimenComparative (mg/dL)Difference (mg/dL)Allowed difference (mg/dL)Outcome
MC-01102+2.0±8.2Met
MC-02131+1.0±10.5Met
MC-03641+1.0±51.3Met
MC-0493+3.0±7.4Met
MC-05149+4.0±11.9Met
MC-06468−1.0±37.4Met
MC-07106+1.0±8.5Met
MC-08163−27.0±13.0Not met
MC-09421+11.0±33.7Met
MC-10157+2.0±12.6Met
MC-1171+2.0±6.0Met
MC-12142+3.0±11.4Met
MC-131710.0±13.7Met
MC-141170.0±9.4Met
MC-15182+4.0±14.6Met
MC-16205+1.0±16.4Met
MC-17194+6.0±15.5Met
MC-18740.0±6.0Met
MC-19218+4.0±17.4Met
MC-20517+9.0±41.4Met
MC-21347+7.0±27.8Met
MC-22122+2.0±9.8Met
MC-2397+1.0±7.8Met
MC-24550.0±6.0Met
MC-25318+1.0±25.4Met
MC-2684+2.0±6.7Met
MC-27249+6.0±19.9Met
MC-2879+2.0±6.3Met
MC-29163+3.0±13.0Met
MC-30126+3.0±10.1Met
MC-31291+8.0±23.3Met
MC-32111+3.0±8.9Met
MC-3342+2.0±6.0Met
MC-3468+1.0±6.0Met
MC-3588+1.0±7.0Met
MC-36574+13.0±45.9Met
MC-372330.0±18.6Met
MC-38382+2.0±30.6Met
MC-39268+3.0±21.4Met
MC-4063+2.0±6.0Met

Difference = test − comparative.

1.2 Differences and limits of agreement

−30−20−100100200400600Test − comparative (mg/dL)Comparative result (mg/dL)Specimen MC-01: difference +2.0 mg/dLSpecimen MC-02: difference +1.0 mg/dLSpecimen MC-03: difference +1.0 mg/dLSpecimen MC-04: difference +3.0 mg/dLSpecimen MC-05: difference +4.0 mg/dLSpecimen MC-06: difference −1.0 mg/dLSpecimen MC-07: difference +1.0 mg/dLSpecimen MC-08: difference −27.0 mg/dLSpecimen MC-09: difference +11.0 mg/dLSpecimen MC-10: difference +2.0 mg/dLSpecimen MC-11: difference +2.0 mg/dLSpecimen MC-12: difference +3.0 mg/dLSpecimen MC-13: difference 0.0 mg/dLSpecimen MC-14: difference 0.0 mg/dLSpecimen MC-15: difference +4.0 mg/dLSpecimen MC-16: difference +1.0 mg/dLSpecimen MC-17: difference +6.0 mg/dLSpecimen MC-18: difference 0.0 mg/dLSpecimen MC-19: difference +4.0 mg/dLSpecimen MC-20: difference +9.0 mg/dLSpecimen MC-21: difference +7.0 mg/dLSpecimen MC-22: difference +2.0 mg/dLSpecimen MC-23: difference +1.0 mg/dLSpecimen MC-24: difference 0.0 mg/dLSpecimen MC-25: difference +1.0 mg/dLSpecimen MC-26: difference +2.0 mg/dLSpecimen MC-27: difference +6.0 mg/dLSpecimen MC-28: difference +2.0 mg/dLSpecimen MC-29: difference +3.0 mg/dLSpecimen MC-30: difference +3.0 mg/dLSpecimen MC-31: difference +8.0 mg/dLSpecimen MC-32: difference +3.0 mg/dLSpecimen MC-33: difference +2.0 mg/dLSpecimen MC-34: difference +1.0 mg/dLSpecimen MC-35: difference +1.0 mg/dLSpecimen MC-36: difference +13.0 mg/dLSpecimen MC-37: difference 0.0 mg/dLSpecimen MC-38: difference +2.0 mg/dLSpecimen MC-39: difference +3.0 mg/dLSpecimen MC-40: difference +2.0 mg/dLLoA +13.2Mean +2.2LoA −8.8
Figure 3. Test − comparative, with the mean and 95% limits of agreement.

Table 4. 95% limits of agreement for individual differences

EstimateDifference (mg/dL)95% CI (mg/dL)Relative (%)95% CI (%)
SD of differences5.64
Lower limit of agreement−8.8−12.0 to −5.7−4.9−6.6 to −3.2
Upper limit of agreement+13.210.1–16.4+7.35.6–9.0

Relative differences are percentages of the comparative result.

1.3 Ranges and fit details

Table 5. Ranges and fit details

ItemValue
Test range44–642 mg/dL
Decision-level CIsFrom the slope and intercept confidence region

1.4 Reportable-range coverage · Coverage describes the span of observed concentrations inside the claimed interval. It does not make an acceptance decision.

Table 6. Observed and claimed ranges

LevelAxisClaimed (mg/dL)Observed (mg/dL)Coverage (%)
*Comparative method2.0–750.042.0–641.080.1

Supporting diagnostics

S.1 Fit diagnostics

Passing–Bablok has no fitted-response band.

−30−20−1000200400600Residual (test − fitted) (mg/dL)Chemistry analyzer B (mg/dL)Specimen MC-01: residual −0.1 mg/dL, group 1Specimen MC-02: residual −1.5 mg/dL, group 1Specimen MC-03: residual −8.5 mg/dL, group 1Specimen MC-04: residual +1.0 mg/dL, group 1Specimen MC-05: residual +1.3 mg/dL, group 1Specimen MC-06: residual −8.1 mg/dL, group 1Specimen MC-07: residual −1.1 mg/dL, group 1Specimen MC-08: residual −29.9 mg/dL, group 1Specimen MC-09: residual +4.5 mg/dL, group 1Specimen MC-10: residual −0.8 mg/dL, group 1Specimen MC-11: residual +0.4 mg/dL, group 1Specimen MC-12: residual +0.4 mg/dL, group 1Specimen MC-13: residual −3.0 mg/dL, group 1Specimen MC-14: residual −2.3 mg/dL, group 1Specimen MC-15: residual +0.8 mg/dL, group 1Specimen MC-16: residual −2.5 mg/dL, group 1Specimen MC-17: residual +2.6 mg/dL, group 1Specimen MC-18: residual −1.7 mg/dL, group 1Specimen MC-19: residual +0.3 mg/dL, group 1Specimen MC-20: residual +1.2 mg/dL, group 1Specimen MC-21: residual +1.5 mg/dL, group 1Specimen MC-22: residual −0.4 mg/dL, group 1Specimen MC-23: residual −1.0 mg/dL, group 1Specimen MC-24: residual −1.4 mg/dL, group 1Specimen MC-25: residual −4.1 mg/dL, group 1Specimen MC-26: residual +0.2 mg/dL, group 1Specimen MC-27: residual +1.9 mg/dL, group 1Specimen MC-28: residual +0.2 mg/dL, group 1Specimen MC-29: residual +0.1 mg/dL, group 1Specimen MC-30: residual +0.6 mg/dL, group 1Specimen MC-31: residual +3.3 mg/dL, group 1Specimen MC-32: residual +0.8 mg/dL, group 1Specimen MC-33: residual +0.8 mg/dL, group 1Specimen MC-34: residual −0.6 mg/dL, group 1Specimen MC-35: residual −0.9 mg/dL, group 1Specimen MC-36: residual +4.4 mg/dL, group 1Specimen MC-37: residual −3.9 mg/dL, group 1Specimen MC-38: residual −4.0 mg/dL, group 1Specimen MC-39: residual −1.4 mg/dL, group 1Specimen MC-40: residual +0.5 mg/dL, group 1
Figure 4. Residuals for Passing-Bablok: test − fitted result against Comparative method. One point per specimen, with replicates averaged.

Table 7. Alternative regressions

RegressionSlope95% CIIntercept (mg/dL)95% CI (mg/dL)
Ordinary least squares (y on x)1.0121.000–1.023−0.161−3.1 to 2.8
Deming1.0120.999–1.025−0.289−3.2 to 2.6
Weighted Deming (constant CV)1.0040.988–1.021+0.900−0.4 to 2.2

The primary Passing–Bablok fit is in the Regression and bias table.

Table 8. Correlation

ItemValueItemValue
Pearson r (OLS)0.9994

B Methods

B.1 Additional study details

CAP COM.40300 · 9 December 2025Unmodified FDA-cleared or approved nonwaived tests. Supporting sections: Decision page; Results; Data listing. Associated laboratory evidence: Written assessment for each test and instrument, including investigation of discordant results.
CAP COM.40475 · 9 December 2025Approval of nonwaived test validation or verification before clinical use. Supporting sections: Decision page; Sign-off. Associated laboratory evidence: Director or qualified designee signed written assessment and approval tied to each test and instrument.
CAP GEN.20377 · 9 December 2025Laboratory record retention. Supporting sections: Evidence archive. Associated laboratory evidence: Keep method validation and verification records for the life of the test plus two years, or longer when applicable retention rules require it.
CAP GEN.20450 · 9 December 2025Corrections to laboratory records. Supporting sections: Data listing; Audit trail. Associated laboratory evidence: Retained original values and traceable corrections.

B.2 Statistical methods applied

  1. Residuals are the test result minus the result fitted by the primary regression line.
  2. The fitted-response confidence band is pointwise. OLS uses Student t(n−2) with the residual SD and leverage. Deming fits use Linnet’s jackknife t(n−2) intervals. Weighted Deming iteration uses a shared concentration scale and a convergence tolerance of 10⁻¹⁰.
  3. Comparative results are x and test results are y. Replicate pairs are averaged to one mean pair per specimen.
  4. Ordinary least squares fits y on x. It assumes the comparative method has negligible error and the test errors have constant variance.
  5. Deming regression uses λ = Var(test error)/Var(comparative error) = 1.000, with constant error variance on both axes. λ is an assumed error-variance ratio. Weighted Deming assumes spread proportional to concentration and needs results above zero. Both use jackknife t(n−2) intervals.
  6. Passing–Bablok is the shifted median of pairwise slopes, with rank-based CIs. It assumes a positive linear relationship and similar error distributions on both axes.
  7. The 95% limits of agreement are mean bias ± 1.96 SD. Mean bias has a 95% Student t CI, and the limits have CIs from SE = √(3s²/n). The CI is for the mean bias. The limits of agreement are for individual differences.
  8. Slope, intercept and bias at each medical decision level come from the primary fit. Bias outside the studied range is inconclusive.
  9. Pearson r, from the least-squares fit, describes linear association and grows with the studied range.
  10. A specimen allowance below 1.96 × the SD of a matched difference from imprecision alone (the pooled repeatability SD of the two methods, from replicate pairs or linked precision studies, times √(2/k) for k replicates per specimen) is cautioned with the share of specimens imprecision alone would put outside it. The caution changes no decision.
  11. Reportable-range coverage is the width of the overlap between the observed reference-axis range and the claimed reportable range, divided by the claimed range width, times 100. It describes the tested span; accuracy and verification of the reportable range are separate questions. Replicate results are averaged by specimen before determining the observed range.

B.3 Decision rules and display precision

  1. Each acceptance criterion compares the unrounded estimate with its limit. Limits include their end values unless marked exclusive. A criterion with a missing estimate, too little data or a failed fit is inconclusive and does not count as met.
  2. Regression lines cover the observed comparative range.
  3. Entered results, claims, targets and acceptance limits are shown as entered. Calculated concentrations, SDs and fitted parameters are shown to 1 decimal place, percentages to 1 decimal place, and slopes to 3 decimal places. r and R² are shown to 4 decimal places. A value that rounds to 1 is shown as > 0.9999. Very small or large values use exponent notation at the same precision. An SD or limit that would round to zero keeps two significant digits.

C Audit trail

Data version3
Criteria version1
Methodmethod comparison with specimen agreement (method ID LMS-CMP-1.26)
Criteria evaluationacceptance criteria evaluation (method ID LMS-CRITERIA-1.1)
Import CHEM-B_CHEM-A_glucose_20260910.csvSHA-256 cc426020f4657d8b2d8f0b35613dcfffe7a4b7a37e2da24b91c91e500227728c
Report software0.1.0 · templates 2a6731123b96